Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Two Pulmonary Embolism Treatments

NCT: NCT05684796 · COMPLETED

NCT IDNCT05684796
StatusCOMPLETED
Start Date2023-11-27
Completion2025-09-09
SponsorPenumbra Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the Indigo Aspiration System for the treatment of intermediate-high risk acute pulmonary embolism (PE).

Frequently Asked Questions

What is Comparison of Two Pulmonary Embolism Treatments?

Comparison of Two Pulmonary Embolism Treatments is a clinical trial registered under NCT05684796. Current status: COMPLETED.

What is the status of NCT05684796?

The current status of NCT05684796 (Comparison of Two Pulmonary Embolism Treatments) is: COMPLETED.

When did Comparison of Two Pulmonary Embolism Treatments start?

Comparison of Two Pulmonary Embolism Treatments started on 2023-11-27.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.